A phase II study evaluating pharmacokinetics and dosimetry of (177)Lu-PSMA-617 radioligand therapy in Chinese participants with progressive metastatic castration-resistant prostate cancer
一项评估(177)Lu-PSMA-617放射性配体疗法在中国进展性转移性去势抵抗性前列腺癌患者中药代动力学和剂量学的II期研究
期刊:Ejnmmi Research
影响因子:3
doi:10.1186/s13550-026-01401-3
Shi, Hongcheng; Guo, Jianming; Fan, Wei; Li, Yonghong; Huang, Rui; Dong, Qiang; Yang, Zhi; Yang, Yong; Wang, Xinlu; Gu, Di; Huo, Li; Ji, Zhigang; Wang, Feng; Xu, Danfeng; Jiang, Zhiqiang; Li, Haifu; Li, Jialu; Li, Runqin; Qi, Luyuan; Wang, Jing; Ye, Dingwei